{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:06:26Z","timestamp":1790809586821,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.it.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:17:51Z","timestamp":1648718271000},"page":"355-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Antigen presentation by MHC-E: a putative target for vaccination?"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-8929","authenticated-orcid":false,"given":"Linda","family":"Voogd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3217-4497","authenticated-orcid":false,"given":"Paula","family":"Ruibal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-3403","authenticated-orcid":false,"given":"Tom H.M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9878-0863","authenticated-orcid":false,"given":"Simone A.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2022.03.002_bb0005","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2022.03.002_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/tan.14195","article-title":"HLA-E diversity unfolded: identification and characterization of 170 novel HLA-E alleles","volume":"97","author":"Paech","year":"2021","journal-title":"HLA"},{"key":"10.1016\/j.it.2022.03.002_bb0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.humimm.2020.12.008","article-title":"HLA-E typing of more than 2.5 million potential hematopoietic stem cell donors: methods and population-specific allele frequencies","volume":"82","author":"Sauter","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0020","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.3390\/ijms20215496","article-title":"Dimorphism of HLA-E and its disease association","volume":"20","author":"Kanevskiy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.it.2022.03.002_bb0025","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.it.2022.03.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000782","article-title":"Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8+ T-cells with cytotoxic as well as regulatory activity","volume":"6","author":"Joosten","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0035","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.2000810","article-title":"Peptide binding to HLA-E molecules in humans, nonhuman primates, and mice reveals unique binding peptides but remarkably conserved anchor residues","volume":"205","author":"Ruibal","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1126\/science.aay7079","article-title":"Mobilizing unconventional T cells","volume":"366","author":"Ottenhoff","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.it.2022.03.002_bb0045","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41467-018-05459-z","article-title":"Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding","volume":"9","author":"Walters","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2022.03.002_bb0050","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/eji.202048719","article-title":"Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay","volume":"50","author":"Walters","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0055","doi-asserted-by":"crossref","first-page":"eabe9233","DOI":"10.1126\/science.abe9233","article-title":"Modulation of MHC-E transport by viral decoy ligands is required for RhCMV\/SIV vaccine efficacy","volume":"372","author":"Verweij","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.it.2022.03.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004743","article-title":"Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution","volume":"11","author":"Verweij","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0065","first-page":"1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2022.03.002_bb0070","doi-asserted-by":"crossref","first-page":"21149","DOI":"10.1074\/jbc.M117.807719","article-title":"A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct \u03b1\u03b2 T cell receptors","volume":"292","author":"Sullivan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2022.03.002_bb0075","doi-asserted-by":"crossref","first-page":"eabg5413","DOI":"10.1126\/sciimmunol.abg5413","article-title":"Cytomegaloviral determinants of CD8 T cell programming and RhCMV\/SIV vaccine efficacy","volume":"6","author":"Malouli","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex-E","volume":"351","author":"Hansen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.it.2022.03.002_bb0085","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class i and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0090","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ni1082","article-title":"Cellular mechanisms governing cross-presentation of exogenous antigens","volume":"5","author":"Ackerman","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0095","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.4049\/jimmunol.167.11.6441","article-title":"Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes","volume":"167","author":"Lemberg","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0100","doi-asserted-by":"crossref","first-page":"33747","DOI":"10.1074\/jbc.M305593200","article-title":"Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E","volume":"278","author":"Bland","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2022.03.002_bb0105","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.1301496","article-title":"New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation","volume":"191","author":"Oliveira","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2018.03.029","article-title":"TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I low cancers","volume":"113","author":"Marijt","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/eji.200838136","article-title":"Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry","volume":"38","author":"Weinzierl","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1034\/j.1600-0854.2000.010808.x","article-title":"Generation of MHC class I peptide antigens by protein processing in the secretory route by furin","volume":"1","author":"Gil-Torregrosa","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.it.2022.03.002_bb0125","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.0901356","article-title":"Furin-processed antigens targeted to the secretory route elicit functional TAP1\u2212\/\u2212 CD8+ T lymphocytes in vivo","volume":"183","author":"Medina","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood-2012-01-402404","article-title":"Autophagy mediates transporter associated with antigen processing- independent presentation of viral epitopes through MHC class I pathway","volume":"120","author":"Tey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2022.03.002_bb0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.1720","article-title":"Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection","volume":"10","author":"English","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/icb.2016.59","article-title":"Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells","volume":"94","author":"Dasari","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.it.2022.03.002_bb0145","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1371\/journal.pbio.0040423","article-title":"Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response","volume":"4","author":"Bernales","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2022.03.002_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1189\/jlb.1A0415-172R","article-title":"Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation","volume":"99","author":"Camilli","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.it.2022.03.002_bb0155","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.163.8.4224","article-title":"Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis","volume":"163","author":"Johnsen","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2012.07.009","article-title":"Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2","volume":"53","author":"Lampen","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00060","article-title":"T cells engaging the conserved MHC class Ib molecule Qa-1b with TAP-independent peptides are semi-invariant lymphocytes","volume":"9","author":"Doorduijn","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.20091429","article-title":"The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects","volume":"207","author":"Oliveira","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2022.03.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1382793","article-title":"T cells specific for a TAP-independent self-peptide remain na\u00efve in tumor-bearing mice and are fully exploitable for therapy","volume":"7","author":"Doorduijn","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.it.2022.03.002_bb0180","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI83671","article-title":"TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors","volume":"126","author":"Doorduijn","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2022.03.002_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.it.2022.03.002_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cei.13292","article-title":"HLA-E: exploiting pathogen-host interactions for vaccine development","volume":"196","author":"Sharpe","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0195","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.1834449100","article-title":"HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes","volume":"100","author":"Pietra","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2022.03.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007041","article-title":"HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition","volume":"14","author":"Jouand","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12967-016-0819-7","article-title":"Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans","volume":"14","author":"Fresnay","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.it.2022.03.002_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046120","article-title":"Epstein\u2013Barr virus peptide presented by HLA-E is predominantly recognized by CD8bright cells in multiple sclerosis patients","volume":"7","author":"J\u00f8rgensen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2022.03.002_bb0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2018.08.005","article-title":"Identification of novel HIV-1-derived HLA-E-binding peptides","volume":"202","author":"Hannoun","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.it.2022.03.002_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004671","article-title":"Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset","volume":"11","author":"van Meijgaarden","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/eji.201747184","article-title":"Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells","volume":"48","author":"Prezzemolo","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00719-19","article-title":"Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression","volume":"93","author":"van Stigt Thans","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2022.03.002_bb0235","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1165\/rcmb.2019-0261OC","article-title":"HLA-E-restricted CD8+ T lymphocytes efficiently control Mycobacterium tuberculosis and HIV-1 coinfection","volume":"62","author":"La Manna","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.it.2022.03.002_bb0240","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.173.9.5852","article-title":"Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine","volume":"173","author":"Salerno-Gon\u00e7alves","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0245","doi-asserted-by":"crossref","first-page":"eabg1703","DOI":"10.1126\/sciimmunol.abg1703","article-title":"HLA-E\u2013restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities","volume":"6","author":"Yang","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0250","doi-asserted-by":"crossref","first-page":"eabe9057","DOI":"10.1126\/sciimmunol.abe9057","article-title":"Natural killer cell receptors regulate responses of HLA-E-restricted T cells","volume":"6","author":"Sullivan","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0255","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/jcmm.12867","article-title":"Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8+ T cell epitopes","volume":"20","author":"Liu","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.it.2022.03.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000374","article-title":"The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle","volume":"5","author":"Grotzke","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006384","article-title":"MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection","volume":"13","author":"Bian","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2022.03.002_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188288","article-title":"T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells","volume":"12","author":"McMurtrey","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2022.03.002_bb0275","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41598-017-04894-0","article-title":"HLA-E presents glycopeptides from the Mycobacterium tuberculosis protein MPT32 to human CD8+ T cells","volume":"7","author":"Harriff","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2022.03.002_bb0280","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.4049\/jimmunol.1000801","article-title":"Secreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway","volume":"185","author":"Grotzke","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1083\/jcb.200510071","article-title":"A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling","volume":"173","author":"Dantuma","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.it.2022.03.002_bb0290","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1462-5822.2012.01799.x","article-title":"ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria","volume":"14","author":"Houben","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.it.2022.03.002_bb0295","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.it.2022.03.002_bb0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature01911","article-title":"ER\u2013phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells","volume":"425","author":"Guermonprez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2022.03.002_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079571","article-title":"TAP mediates import of Mycobacterium tuberculosis-derived peptides into phagosomes and facilitates loading onto HLA-I","volume":"8","author":"Harriff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2022.03.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148979","article-title":"HLA-E-restricted HIV-1\u2013specific CD8+ T cell responses in natural infection","volume":"131","author":"Bansal","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2022.03.002_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imr.12948","article-title":"The role of donor-unrestricted T-cells, innate lymphoid cells, and NK cells in anti-mycobacterial immunity","volume":"301","author":"Ruibal","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2022.03.002_bb0320","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/eji.1830270517","article-title":"The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9","volume":"27","author":"Braud","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0325","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.192.5.613","article-title":"Analysis of Qa-1b peptide binding specificity and the capacity of CD94\/NKG2A to discriminate between Qa-1-peptide complexes","volume":"192","author":"Kraft","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2022.03.002_bb0330","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4049\/jimmunol.171.3.1369","article-title":"Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94\/NKG2","volume":"171","author":"Miller","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2022.03.002_bb0335","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1097-2765(00)80053-2","article-title":"Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E","volume":"1","author":"O\u2019Callaghan","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2022.03.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00592-19","article-title":"Vaccine-mediated inhibition of the transporter associated with antigen processing is insufficient to induce major histocompatibility complex E-restricted CD8+ T cells in nonhuman primates","volume":"93","author":"Abdulhaqq","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2022.03.002_bb0345","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.4049\/jimmunol.1900795","article-title":"MHC-E-restricted CD8+ T cells target hepatitis B virus-infected human hepatocytes","volume":"204","author":"Burwitz","year":"2020","journal-title":"J. Immunol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490622000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490622000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:10:40Z","timestamp":1761462640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490622000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1471490622000515"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2022.03.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen presentation by MHC-E: a putative target for vaccination?","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}